CHICAGO, May 20, 2025 /PRNewswire/ — Prominence Advisors is proud to announce that our Founder and CEO, Bobby Bacci, has been named a finalist for the Entrepreneur Of The Year® 2025 Midwest Award by Ernst & Young LLP (EY US). Now in its 40th year, the program celebrates leaders who are driving innovation, transforming industries, and creating long-term value through their vision and dedication.
For Bobby, this honor is not a solo achievement — it’s a reflection of the exceptional people who have adopted the vision of Prominence and shaped the company into organization it is today.
Bobby’s recognition is a testament to what’s possible when a company aligns purpose, passion and action, and to the entire team for delivering day-in and day-out.
Prominence was founded in 2011 by former Epic leaders with the goal of enabling healthcare organizations to do more with their data. Our core values of Do Great Work and Move Mountains are reflected in the extraordinary level of service our team provides our customers, recently winning Best in KLAS for Technical Services in 2023 and Best in KLAS for HIT Staffing in 2024 while continuing to be highly rated across all service lines.
Prominence supports more than 120 healthcare organizations across the US with pre-built templates and processes for analytics and governance, and an Epic team with certifications in every module.
Advanced Analytics
|
Data Harmonization |
Intelligent Automation |
|
Data Modernization |
Generative AI |
|
Data Science, Machine Learning |
Real-time Read / Write-back to Epic |
|
De-identification, OMOP Build |
Governed Self-Service |
|
Visualization |
Coaching and Knowledge Transfer |
Data Strategy
|
Strategic Roadmapping |
Data Monetization and ROI |
|
Literacy & Stewardship |
Glossary, Catalog, Data Quality, MDM |
Epic Services
|
Epic Cogito Reporting Managed Services |
Revenue Cycle Optimization |
|
Merger, Upgrade, Rollout Packages |
Staff Augmentation |
Learn more about Prominence Advisors at https://prominenceadvisors.com/
Learn more about the Entrepreneur Of The Year® program at ey.com/us/eoy.
SOURCE Prominence Advisors
ATLANTA, GA AND DOHA, QATAR / ACCESS Newswire / December 6, 2025 / Ameerex Corporation…
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…